BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8578513)

  • 1. Issues in the development of thrombin receptor antagonists.
    Brass LF
    Thromb Haemost; 1995 Jul; 74(1):499-505. PubMed ID: 8578513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin receptors: turning them off after turning them on.
    Brass LF; Ahuja M; Belmonte E; Blanchard N; Pizarro S; Tarver A; Hoxie JA
    Semin Hematol; 1994 Jul; 31(3):251-60. PubMed ID: 7973781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through G proteins and G protein-coupled receptors during platelet activation.
    Brass LF; Hoxie JA; Manning DR
    Thromb Haemost; 1993 Jul; 70(1):217-23. PubMed ID: 8236108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a peptide antagonist to the thrombin receptor using phage display.
    Doorbar J; Winter G
    J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
    Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
    Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the thrombin receptor in development and evidence for a second receptor.
    Connolly AJ; Ishihara H; Kahn ML; Farese RV; Coughlin SR
    Nature; 1996 Jun; 381(6582):516-9. PubMed ID: 8632823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin receptor structure and function.
    Coughlin SR
    Thromb Haemost; 1993 Jul; 70(1):184-7. PubMed ID: 8236100
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease activated receptors: theme and variations.
    O'Brien PJ; Molino M; Kahn M; Brass LF
    Oncogene; 2001 Mar; 20(13):1570-81. PubMed ID: 11313904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist receptors and G proteins as mediators of platelet activation.
    Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M
    Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombin induced tumour growth - pharmacological control].
    Nowak G; Lopez M; Zieger M
    Hamostaseologie; 2007 May; 27(2):105-10. PubMed ID: 17479173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells.
    DiCuccio MN; Shami P; Hoffman M
    Exp Hematol; 1996 Jul; 24(8):914-8. PubMed ID: 8690050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways of the thrombin receptor.
    Van Obberghen-Schilling E; Pouysségur J
    Thromb Haemost; 1993 Jul; 70(1):163-7. PubMed ID: 8236094
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin receptor antagonists as novel therapeutic targets.
    Chackalamannil S
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):417-27. PubMed ID: 11727307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.